Among hypothalamic–pituitary–adrenal axis dysregulation, monoamine and glutaminergic neurotransmission alterations or neurotrophins imbalance, inflammation and immune dysfunctions have been proposed as possible underlying pathways in mood disorders, both MDD and BD [2,7,8,9]. The gene discussed is BDNF; the disease is major depressive disorder.